SecProbe.io

Probe score transparency
Intelligence Terminal Search Topics Monthly Activity About

Probe Score Transparency

Silexion Therapeutics Corp (SLXN)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Probe Score
4.5 / 10
Letters
3
Latest Activity
Sep. 30, 2025
Version
v1

Score Breakdown

Letter Count
3.0
Sentiment / Tone
1.5
Keywords
0.0
Signals
0.0
Notable 8-K Modifier
0.0
Notable 8-K Count
0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

DateFormSentimentUrgencySummaryOpen
Sep. 30, 2025 CORRESP Neutral/Informational High Silexion Therapeutics Corp has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3, which was filed on September 26, 2025. … Read Filing EDGAR
Sep. 29, 2025 UPLOAD Neutral/Informational Low The SEC has communicated to Silexion Therapeutics Corp that it will not review their registration statement filed on September 26, 2025. The letter emphasizes the company's respon… Read Filing EDGAR
Sep. 9, 2025 CORRESP Neutral/Informational High Silexion Therapeutics Corp has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-1, which was filed on September 5… Read Filing EDGAR
Sep. 9, 2025 CORRESP Neutral/Informational Moderate The correspondence from H.C. Wainwright & Co., LLC to the U.S. Securities and Exchange Commission (SEC) pertains to Silexion Therapeutics Corp's request for the acceleration of th… Read Filing EDGAR
Sep. 2, 2025 CORRESP Neutral/Informational Moderate Silexion Therapeutics Corp has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1, which was filed on August 26,… Read Filing EDGAR
Aug. 28, 2025 UPLOAD Neutral/Informational Low The SEC has communicated to Silexion Therapeutics Corp that they will not review the company's registration statement filed on August 26, 2025. The SEC reminds the company that it… Read Filing EDGAR
Apr. 28, 2025 UPLOAD Neutral/Informational Low The SEC has communicated to Silexion Therapeutics Corp that it does not intend to review their Draft Registration Statement on Form S-1 filed on April 23, 2025. The SEC has reques… Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.